628 related articles for article (PubMed ID: 17309182)
21. Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera.
Manoussakis MN; Garalea KL; Tzioufas AG; Moutsopoulos HM
Clin Rheumatol; 1988 Dec; 7(4):465-9. PubMed ID: 3073034
[TBL] [Abstract][Full Text] [Related]
22. Antibodies against extractable nuclear antigen in non-Hodgkin lymphoma patients.
Gergely L; Dankó A; Csípõ I; Váróczy L; Sipka S; Zeher M; Illés A
Scand J Immunol; 2005 Apr; 61(4):343-6. PubMed ID: 15853917
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of anticentromere F protein autoantibodies in 347 patients with non-Hodgkin's lymphoma.
Bencimon C; Salles G; Moreira A; Guyomard S; Coiffier B; Bienvenu J; Fabien N
Ann N Y Acad Sci; 2005 Jun; 1050():319-26. PubMed ID: 16014548
[TBL] [Abstract][Full Text] [Related]
24. The clinical significance of antinuclear antibodies in connective tissue disease.
Pahor A; Krajnc I; Gorenjak M; Holc I
Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of autoantibodies in SAPHO syndrome: a single-center study of 90 patients.
Grosjean C; Hurtado-Nedelec M; Nicaise-Roland P; Ferreyra-Dillon R; Bollet C; Quintin E; Dieude P; Palazzo E; Wattiaux MJ; Kahn MF; Meyer O; Chollet-Martin S; Hayem G
J Rheumatol; 2010 Mar; 37(3):639-43. PubMed ID: 20110527
[TBL] [Abstract][Full Text] [Related]
27. Application of linear discriminant analysis in performance evaluation of extractable nuclear antigen immunoassay systems in the screening and diagnosis of systemic autoimmune rheumatic diseases.
Pi D; de Badyn MH; Nimmo M; White R; Pal J; Wong P; Phoon C; O'Connor D; Pi S; Shojania K
Am J Clin Pathol; 2012 Oct; 138(4):596-603. PubMed ID: 23010715
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY
Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609
[TBL] [Abstract][Full Text] [Related]
29. [Autoantibodies in systemic lupus erythematosus: spectrum and clinical associations].
Haddouk S; Ben Ayed M; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
Pathol Biol (Paris); 2005 Jul; 53(6):311-7. PubMed ID: 16004941
[TBL] [Abstract][Full Text] [Related]
30. The significance of persistent newly developed autoantibodies in JIA patients under long-term anti-TNF treatment.
Kanakoudi-Tsakalidou F; Tzimouli V; Pratsidou-Gertsi P; Chronopoulou E; Trachana M
Cytokine; 2008 Jun; 42(3):293-7. PubMed ID: 18445529
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune markers in lymphoid malignancies.
Sjöberg K; Roth EB; Gustavsson L; Jönsson C; Simán H; Henriksson G; Stenberg P; Lindblom A; Svensson P
Scand J Immunol; 2008 May; 67(5):509-15. PubMed ID: 18405328
[TBL] [Abstract][Full Text] [Related]
32. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
[TBL] [Abstract][Full Text] [Related]
33. Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule-1: a reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases?
Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
Arch Immunol Ther Exp (Warsz); 2001; 49(6):423-30. PubMed ID: 11814236
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study.
Olsen ML; O'Connor S; Arnett FC; Rosenbaum D; Grotta JC; Warner NB
Am J Med; 1991 Apr; 90(4):479-88. PubMed ID: 1901447
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
36. [Detection of autoantibodies to extractable nuclear antigens in autoimmune diseases of rheumatic origin using immunoblotting--comparison with counter-electrophoresis].
Hiepe F; Kiessig ST; Yamamoto K; Prokop G; Mielke F; Lukowsky A; Schlaak B; Miyamoto T; Apostoloff E
Z Rheumatol; 1990; 49(5):304-9. PubMed ID: 2080688
[TBL] [Abstract][Full Text] [Related]
37. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
38. Detection of autoantibodies to nuclear antigens by EIA and IF techniques.
Alem M; Moghadam S; Malki J; Zaidi A; Nayak N; Li TM
Allerg Immunol (Paris); 1997 Sep; 29(7):188, 191-4. PubMed ID: 9373708
[TBL] [Abstract][Full Text] [Related]
39. High sensitive detection of double-stranded DNA autoantibodies by a modified Crithidia luciliae immunofluorescence test.
Conrad K; Ittenson A; Reinhold D; Fischer R; Roggenbuck D; Büttner T; Bosselmann HP; Steinbach J; Schössler W
Ann N Y Acad Sci; 2009 Sep; 1173():180-5. PubMed ID: 19758148
[TBL] [Abstract][Full Text] [Related]
40. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens.
Almeida González D; Cabrera de León A; Rodríguez Pérez Mdel C; Brito Díaz B; González Hernández A; García García D; Vázquez Moncholi C; Aguirre Jaime A
J Immunol Methods; 2010 Aug; 360(1-2):89-95. PubMed ID: 20600078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
